Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Malignant peripheral nerve sheath tumor

Malignant peripheral nerve sheath tumor

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Malignant peripheral nerve sheath tumor

2 trials tracked for Malignant peripheral nerve sheath tumor.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Sorafenib and Dacarbazine in Soft Tissue Sarcoma Completed
  2. Phase 2 Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Hepatic MPNST without NF1: normal tumor markers, no recurrence 2 years after resection
Oncology Sys. Review
Hepatic MPNST without NF1: normal tumor markers, no recurrence 2 years after resection Case Report Shows Surgery for Rare Liver Tumor Success
A case report and literature review describes a 56-year-old woman with hepatic malignant peripheral nerve sheath tumor (MPNST) without neuro…
A rare liver tumor known as MPNST was successfully treated with surgery, showing no signs of return after two years.
Frontiers Jun 12, 2026